AP
ABBV icon

Anchyra Partners’s AbbVie ABBV Stock Holding History

Anchyra Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
5,386
-13
-0.2% -$2.8K 0.33% 61
2026
Q1 		$1.17M Buy
5,399
+343
+7% +$76.1K 0.36% 53
2025
Q4 		$1.16M Buy
+5,056
New +$1.15M 0.35% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Anchyra Partners's ABBV Position: Q2 2026 in Review

Anchyra Partners reduced its AbbVie (ABBV) stake by 0.24% in Q2 2026, selling an estimated $2.8K and leaving 5,386 shares worth $1.36M. The position accounts for 0.33% of the portfolio, ranked #61.

Anchyra Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Anchyra Partners held 5,386 shares of AbbVie worth $1.36M as of Q2 2026.
  • Anchyra Partners sold 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 0.33% of Anchyra Partners's portfolio in Q2 2026, its #61 holding.
  • Anchyra Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.